Reviva Pharmaceuticals Holdings, Inc.
NASDAQ:RVPH
Cash Flow Statement
Cash Flow Statement
Reviva Pharmaceuticals Holdings, Inc.
| May-2019 | Aug-2019 | Nov-2019 | Feb-2020 | May-2020 | Aug-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||||||
| Net Income |
1
|
1
|
1
|
1
|
0
|
(1)
|
(4)
|
(5)
|
(6)
|
(8)
|
(9)
|
(15)
|
(19)
|
(20)
|
(24)
|
(24)
|
(31)
|
(38)
|
(39)
|
(40)
|
(36)
|
(33)
|
(30)
|
(29)
|
(27)
|
(23)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
3
|
1
|
(1)
|
(1)
|
2
|
2
|
2
|
2
|
|
| Other Non-Cash Items |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
2
|
1
|
1
|
1
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
4
|
4
|
4
|
4
|
1
|
1
|
1
|
2
|
2
|
2
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(0)
|
0
|
0
|
0
|
0
|
1
|
(2)
|
(4)
|
(3)
|
(3)
|
(1)
|
2
|
3
|
2
|
5
|
2
|
5
|
10
|
7
|
4
|
(0)
|
(1)
|
(5)
|
(3)
|
(2)
|
(7)
|
|
| Cash from Operating Activities |
(0)
N/A
|
(0)
+11%
|
(0)
-16%
|
(0)
-60%
|
(0)
+1%
|
(1)
-49%
|
(4)
-544%
|
(7)
-68%
|
(8)
-19%
|
(10)
-25%
|
(11)
-5%
|
(14)
-30%
|
(16)
-19%
|
(18)
-10%
|
(19)
-4%
|
(21)
-9%
|
(22)
-6%
|
(24)
-10%
|
(28)
-17%
|
(32)
-13%
|
(35)
-10%
|
(33)
+5%
|
(34)
-1%
|
(30)
+11%
|
(27)
+12%
|
(28)
-5%
|
|
| Investing Cash Flow | |||||||||||||||||||||||||||
| Other Items |
0
|
0
|
0
|
6
|
32
|
32
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
0
N/A
|
6
N/A
|
32
+470%
|
32
-1%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | |||||||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
(6)
|
(33)
|
(33)
|
0
|
0
|
31
|
31
|
32
|
32
|
0
|
8
|
8
|
8
|
13
|
6
|
33
|
0
|
30
|
34
|
23
|
23
|
31
|
36
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
1
|
1
|
1
|
3
|
3
|
3
|
2
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
|
| Other |
(0)
|
0
|
0
|
0
|
0
|
0
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
65
N/A
|
0
N/A
|
0
N/A
|
(6)
N/A
|
(32)
-482%
|
(32)
+1%
|
13
N/A
|
12
-3%
|
71
+465%
|
70
0%
|
32
-55%
|
32
+0%
|
0
-100%
|
8
+7 892%
|
8
-1%
|
8
+9%
|
14
+61%
|
6
-57%
|
33
+460%
|
33
-1%
|
30
-8%
|
34
+12%
|
24
-30%
|
23
-1%
|
31
+32%
|
36
+16%
|
|
| Change in Cash | |||||||||||||||||||||||||||
| Net Change in Cash |
0
N/A
|
(0)
N/A
|
(0)
-16%
|
(0)
+9%
|
(0)
+69%
|
(0)
-158%
|
9
N/A
|
6
-36%
|
36
+532%
|
34
-6%
|
21
-38%
|
18
-15%
|
(16)
N/A
|
(10)
+37%
|
(11)
-8%
|
(12)
-9%
|
(8)
+32%
|
(18)
-120%
|
5
N/A
|
1
-85%
|
(5)
N/A
|
1
N/A
|
(10)
N/A
|
(7)
+32%
|
4
N/A
|
8
+82%
|
|
| Free Cash Flow | |||||||||||||||||||||||||||
| Free Cash Flow |
(0)
N/A
|
(0)
+11%
|
(0)
-16%
|
(0)
-60%
|
(0)
+1%
|
(1)
-49%
|
(4)
-544%
|
(7)
-68%
|
(8)
-19%
|
(10)
-25%
|
(11)
-5%
|
(14)
-30%
|
(16)
-19%
|
(18)
-10%
|
(19)
-4%
|
(21)
-9%
|
(22)
-6%
|
(24)
-10%
|
(28)
-17%
|
(32)
-13%
|
(35)
-10%
|
(33)
+5%
|
(34)
-1%
|
(30)
+11%
|
(27)
+12%
|
(28)
-5%
|
|